Placebo News and Research

RSS

Randomized clinical food trials: Best clinical practice, quality management & data processing

The evolution of food clinical trials highlights the importance of quality management and ICH-GCP adherence in validating health claims and interventions.

From Atlantia Clinical Trials 28 Feb 2025

Stress & Distress: Designing clinical trials for maximum efficacy

To be decided by the editor

From Atlantia Clinical Trials 28 Feb 2025

Atlantia Clinical Trials: Investigating the interrelation of microbiology and immunology

Atlantia Clinical Trials investigates the role of microbiomes in immunity, focusing on gut and lung interactions to develop innovative health solutions.

From Atlantia Clinical Trials 28 Feb 2025

Elderly populations: Global trends in the healthy aging market

To be decided by the editor

From Atlantia Clinical Trials 28 Feb 2025

Research shows exercise can delay Alzheimer’s, but there’s a catch

Regular physical activity slows the accumulation of p-tau181, a key Alzheimer’s biomarker, but its cognitive benefits diminish when tau levels are high.

26 Feb 2025

Do vitamin D supplements reduce acute respiratory infections?

Vitamin D supplementation shows no significant effect on acute respiratory infections overall, but children and daily low doses may offer protective benefits.

25 Feb 2025

Melatonin supplements may help reduce DNA damage in night shift workers

Melatonin supplementation may help offset the DNA damage associated with night shift work by boosting the body's ability to repair it, suggest the findings of a small clinical trial published online in the journal Occupational & Environmental Medicine.

24 Feb 2025

New drug ataciguat shows promise for managing aortic valve stenosis

Aortic valve stenosis (AVS) is a significant health concern affecting over 1.5 million Americans and millions more globally.

24 Feb 2025

Can red ginseng prevent diabetes? New research uncovers its potential

Red ginseng extract powder significantly improved glycemic control in prediabetic Korean adults over 12 weeks without adverse effects. The findings suggest its potential role in diabetes prevention, though larger studies are needed.

23 Feb 2025

Inhalable gene therapy tested for cystic fibrosis treatment in the UK and Europe

An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their mutation type, is being tested in human trials in the UK and Europe.

20 Feb 2025

Vimseltinib gains FDA approval for treating tenosynovial giant cell tumor

The U.S. Food and Drug Administration (FDA) has approved vimseltinib (RomvimzaTM) for adult patients with a rare condition called tenosynovial giant cell tumor (TGCT). TGCT is a tumor of the tissue that lines the joints.

20 Feb 2025

Vitamin E significantly improves liver health in MASH patients, new study finds

A 96-week clinical trial found that 300 mg of Vitamin E significantly improved liver histology and reduced inflammation in patients with MASH, with no major safety concerns reported.

19 Feb 2025

Nerinetide shows promise in stroke treatment meta-analysis

The Calgary Stroke Program, a joint University of Calgary and Alberta Health Services initiative at Foothills Medical Centre, has been involved with three papers published this week in The Lancet and Lancet Neurology-the ESCAPE-NEXT trial, the FRONTIER trial, and an individual patient-level meta-analysis across three trials.

19 Feb 2025

Study suggests taxifolin could be a safe, natural way to aid weight loss

A new study suggests that daily taxifolin intake may support weight loss in older adults, possibly through brown fat activation and cholesterol regulation.

18 Feb 2025

Do probiotics enhance sports performance?

Researchers found that probiotics may enhance endurance, recovery, and immune function in athletes, but the evidence for strength and power performance remains limited.

17 Feb 2025

Groundbreaking ALS platform trial accelerates research and drug testing

Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with few treatment options. Since 2018, the Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital (MGH), a founding member of the Mass General Brigham healthcare system, has been working with national and international stakeholders to accelerate ALS research by launching the first platform trial in ALS to simultaneously test multiple drugs using shared trial infrastructure and placebo data.

17 Feb 2025

Sotagliflozin could be used to reduce the risk of deadly cardiovascular events, trial shows

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart attack and stroke among these patients, according to results from an international clinical trial led by a Mount Sinai researcher.

14 Feb 2025